Philips Mobile App Boosts Compliance According to New Study

 

A new study presented at SLEEP 2014 by Philips Respironics concluded that patients using the SleepMapper mobile app and web-based ­solution achieved a 22% higher positive airway pressure (PAP) therapy adherence rate than non-users. The results of the study further the evidence that patient engagement in care can lead to behavioral change and ultimately, better results and healthier populations.

 

“Healthcare is changing, and if you’re in the business of making people healthier, you’re in the business of behavior change,” said Dr. Mark Aloia, Senior Director of Global Clinical Research for Philips Healthcare. “Study results of SleepMapper demonstrate that technology can shape how patients respond to PAP therapy by improving engagement and motivation and ultimately leading them to a better course of treatment for their chronic condition.”

 

To test the effectiveness of SleepMapper, researchers randomly analyzed more than 15,000 patients from the Philips Respironics EncoreAnywhere database and compared adherence and usage rates between those who were provided with SleepMapper upon initial PAP setup and those who were not. Patients who were provided with SleepMapper achieved a 78% adherence rate based upon the Centers for Medicare and Medicaid (CMS) guidelines, compared to the average 56% compliance rate among patients who were not provided with SleepMapper.

 

In addition, patients who were provided with SleepMapper slept an average of 1.4 hours longer on PAP than patients who were not provided with SleepMapper. As for new PAP patients struggling to manage and accept their therapy, 33% of those who engaged with SleepMapper were able to meet adherence guidelines within 90 days, compared to just 11% who were not provided with the tool.

 

Designed by a team of sleep and psychological experts from Philips Respironics with the goal of improving therapy adherence by changing patient behavior, SleepMapper is an interactive mobile and web-based application that enables patients to take a more active role in their PAP therapy and better utilize their PAP device for more effective treatment.

 

SleepMapper engages patients by providing them with feedback on their individual adherence and therapy information, while also using empirically-tested behavior change therapies to motivate patients and keep them interested. SleepMapper works with Philips Respironics’ EncoreAnywhere patient management system and most of its System One devices to offer a complete therapy and compliance package.

Related Posts